Meijun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meijun Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anqi Tang
School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publication - Hong Yan
Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publication - Jun Chen
Department of Critical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publication - Liangbin Zhao
Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publication - Ling Wu
Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publication - Lizeyu Lv
School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 68 (4) , 480-487
Rituximab in the Treatment of Subarachnoid Hemorrhage and Widespread Bleeding in Microscopic Polyangiitis : A Case Report
Microscopic polyangiitis (MPA) is a rare autoimmune disorder characterized by small-vessel vasculitis and the presence of anti-neutrophil cytoplasmic antibody (ANCA). Typically, MPA primarily affects the respiratory system, kidneys, and skin, with infrequent involvement of the nervous system, resulting in neuropathy. However, the occurrence of subarachnoid hemorrhage (SAH) in MPA is exceedingly rare, especially when it is accompanied by hemorrhagic events in multiple organs. This case report details the clinical presentation of a 61-yearold male patient diagnosed with MPA who experienced an exceptionally uncommon occurrence of SAH, coupled with extensive bleeding manifestations including epistaxis, skin purpura, and gastrointestinal bleeding. Notably, the patient's symptoms exhibited potential improvement following a treatment regimen consisting of rituximab and glucocorticoids. This case emphasizes the critical importance of promptly recognizing and comprehensively managing rare complications in MPA patients to optimize clinical outcomes.
- 1 July 2025
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 68 (4) , 480-487
Open AccessRituximab in the Treatment of Subarachnoid Hemorrhage and Widespread Bleeding in Microscopic Polyangiitis : A Case Report
Microscopic polyangiitis (MPA) is a rare autoimmune disorder characterized by small-vessel vasculitis and the presence of anti-neutrophil cytoplasmic antibody (ANCA). Typically, MPA primarily affects the respiratory system, kidneys, and skin, with infrequent involvement of the nervous system, resulting in neuropathy. However, the occurrence of subarachnoid hemorrhage (SAH) in MPA is exceedingly rare, especially when it is accompanied by hemorrhagic events in multiple organs. This case report details the clinical presentation of a 61-yearold male patient diagnosed with MPA who experienced an exceptionally uncommon occurrence of SAH, coupled with extensive bleeding manifestations including epistaxis, skin purpura, and gastrointestinal bleeding. Notably, the patient's symptoms exhibited potential improvement following a treatment regimen consisting of rituximab and glucocorticoids. This case emphasizes the critical importance of promptly recognizing and comprehensively managing rare complications in MPA patients to optimize clinical outcomes.